| Symbol | Sector | Firm | Action | Grade | Target | Mkt Cap ▼ | Base | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CSCO | Technology | Wolfe Research | Downgrade | Outperform → Peer Perform | — | $461.3B | $40.37 | -0.5% | -1.4% | -1.9% | +0.7% | -2.6% | -1.1% |
| HD | Consumer Cyclical | Oppenheimer | Downgrade | Outperform → Perform | — | $301.5B | $279.96 | -0.6% | -1.7% | -1.0% | +0.4% | -2.5% | -0.3% |
| LOW | Consumer Cyclical | Oppenheimer | Downgrade | Outperform → Perform | — | $122.3B | $163.78 | -1.5% | -2.2% | -0.3% | +1.2% | -1.8% | -0.1% |
| NVCR | Healthcare | Wells Fargo | Downgrade | Overweight → Equal Weight | — | $1.9B | $108.98 | -1.6% | +1.6% | -5.1% | -0.9% | +1.7% | -2.1% |
| BYND | Consumer Defensive | JP Morgan | Downgrade | Neutral → Underweight | — | $137M | $157.22 | -4.6% | -5.2% | -0.2% | +3.4% | -2.1% | -1.8% |
| MCRB | Healthcare | Chardan Capital | Downgrade | Buy → Neutral | — | $74M | $537.20 | -2.6% | -4.5% | +2.4% | +0.8% | -3.9% | -0.9% |